Several studies on salvage radiotherapy for macroscopic prostate cancer recurrence did not employ, or only partly employed, PSMA PET/CT as pre-SRT staging [10,11,12,13,14,15,16,17]. The gene discussed is FOLH1; the disease is Familial prostate cancer.